A detailed history of Smith Shellnut Wilson LLC transactions in Pfizer Inc stock. As of the latest transaction made, Smith Shellnut Wilson LLC holds 9,449 shares of PFE stock, worth $269,579. This represents 0.13% of its overall portfolio holdings.

Number of Shares
9,449
Previous 9,449 -0.0%
Holding current value
$269,579
Previous $264,000 3.41%
% of portfolio
0.13%
Previous 0.13%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$25.26 - $29.6 $152,368 - $178,547
-6,032 Reduced 38.96%
9,449 $264,000
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $10,771 - $14,061
-258 Reduced 1.64%
15,481 $793,000
Q1 2022

May 02, 2022

SELL
$45.75 - $56.69 $31,979 - $39,626
-699 Reduced 4.25%
15,739 $815,000
Q1 2021

Apr 06, 2021

SELL
$33.49 - $37.77 $77,998 - $87,966
-2,329 Reduced 12.41%
16,438 $596,000
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $22,193 - $26,037
699 Added 3.87%
18,767 $689,000
Q1 2020

Apr 20, 2020

SELL
$27.03 - $38.62 $729 - $1,042
-27 Reduced 0.15%
18,068 $590,000
Q4 2019

Feb 05, 2020

BUY
$32.92 - $37.36 $3,226 - $3,661
98 Added 0.54%
18,095 $709,000
Q3 2019

Nov 06, 2019

BUY
$32.49 - $42.13 $32 - $42
1 Added 0.01%
17,997 $647,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $35,389 - $39,734
-957 Reduced 5.05%
17,996 $780,000
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $37 - $41
1 Added 0.01%
18,953 $805,000
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $38 - $43
1 Added 0.01%
18,952 $827,000
Q3 2018

Oct 09, 2018

SELL
$34.47 - $41.81 $121,403 - $147,254
-3,522 Reduced 15.67%
18,951 $835,000
Q1 2018

Apr 24, 2018

BUY
$31.91 - $37.02 $31 - $37
1 Added 0.0%
22,473 $798,000
Q4 2017

Feb 22, 2018

BUY
$33.26 - $35.29 $33 - $35
1 Added 0.0%
22,472 $814,000
Q3 2017

Nov 17, 2017

BUY
$31.0 - $34.15 $696,601 - $767,384
22,471
22,471 $802,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Smith Shellnut Wilson LLC Portfolio

Follow Smith Shellnut Wilson LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Shellnut Wilson LLC , based on Form 13F filings with the SEC.

News

Stay updated on Smith Shellnut Wilson LLC with notifications on news.